Serum Institute of India joins CEPI global network

The Serum Institute of India (SII), which claims to be the world’s largest vaccine manufacturer, is joining a growing Coalition for Epidemic Preparedness Innovation (CEPI) network of vaccine producers in the Global South to support more rapid, agile, and equitable responses to future public health disease outbreaks.

The Indian group says the addition of SII to the CEPI manufacturing network will be a significant boost to vaccine production efforts in Global South regions and will mean the world is better prepared to achieve  the 100 Days Mission to develop new vaccines against known or novel infectious diseases within three months of a pandemic threat being recognized.

CEPI investing $30 million